Per citar aquest document: http://ddd.uab.cat/record/142514
On insurance and the cost-sharing of pharmaceutical R&D
Martínez Giralt, Xavier (Universitat Autònoma de Barcelona. Departament d'Economia i d'Història Econòmica)
Barros, Pedro Pita (Universidade Nova de Lisboa)
Centre de Referència en Economia Analítica

Publicació: Centre de Referencia en Economia Analítica, 2006
Descripció: 18 p.
Col·lecció: Barcelona economics working papers series; 293
Resum: Ramsey pricing has been proposed in the pharmaceutical industry as a principle to price discriminate among markets while allowing to recover the (fixed) R&D cost. However, such analyses neglect the presence of insurance or the fund raising costs for drug reimbursement. By incorporating these new elements, we aim at providing some building blocks towards an economic theory merging Ramsey pricing, equity concerns by governments and the strategic incentives, as governments also determine the reimbursement level in countries with a NHS-like system. This will have important implications to the application of Ramsey pricing principles to pharmaceutical products across countries.
Drets: Tots els drets reservats
Llengua: Anglès
Document: workingPaper
Matèria: Preus ; Indústria farmacèutica ; Ramsey pricing ; Coinsurance

Adreça alternativa: http://www.barcelonagse.eu/sites/default/files/working_paper_pdfs/293.pdf


18 p, 118.4 KB

El registre apareix a les col·leccions:
Documents de recerca > Working papers

 Registre creat el 2015-10-26, darrera modificació el 2016-04-15



   Favorit i Compartir